201 related articles for article (PubMed ID: 15324904)
1. Substituted piperazines as novel dipeptidyl peptidase IV inhibitors.
Brockunier LL; He J; Colwell LF; Habulihaz B; He H; Leiting B; Lyons KA; Marsilio F; Patel RA; Teffera Y; Wu JK; Thornberry NA; Weber AE; Parmee ER
Bioorg Med Chem Lett; 2004 Sep; 14(18):4763-6. PubMed ID: 15324904
[TBL] [Abstract][Full Text] [Related]
2. Discovery of potent and selective beta-homophenylalanine based dipeptidyl peptidase IV inhibitors.
Xu J; Ok HO; Gonzalez EJ; Colwell LF; Habulihaz B; He H; Leiting B; Lyons KA; Marsilio F; Patel RA; Wu JK; Thornberry NA; Weber AE; Parmee ER
Bioorg Med Chem Lett; 2004 Sep; 14(18):4759-62. PubMed ID: 15324903
[TBL] [Abstract][Full Text] [Related]
3. Potent and selective proline derived dipeptidyl peptidase IV inhibitors.
Edmondson SD; Mastracchio A; Beconi M; Colwell LF; Habulihaz B; He H; Kumar S; Leiting B; Lyons KA; Mao A; Marsilio F; Patel RA; Wu JK; Zhu L; Thornberry NA; Weber AE; Parmee ER
Bioorg Med Chem Lett; 2004 Oct; 14(20):5151-5. PubMed ID: 15380217
[TBL] [Abstract][Full Text] [Related]
4. Discovery of potent, selective, and orally bioavailable oxadiazole-based dipeptidyl peptidase IV inhibitors.
Xu J; Wei L; Mathvink RJ; Edmondson SD; Eiermann GJ; He H; Leone JF; Leiting B; Lyons KA; Marsilio F; Patel RA; Patel SB; Petrov A; Scapin G; Wu JK; Thornberry NA; Weber AE
Bioorg Med Chem Lett; 2006 Oct; 16(20):5373-7. PubMed ID: 16919457
[TBL] [Abstract][Full Text] [Related]
5. Triazolopiperazine-amides as dipeptidyl peptidase IV inhibitors: close analogs of JANUVIA (sitagliptin phosphate).
Kim D; Kowalchick JE; Edmondson SD; Mastracchio A; Xu J; Eiermann GJ; Leiting B; Wu JK; Pryor KD; Patel RA; He H; Lyons KA; Thornberry NA; Weber AE
Bioorg Med Chem Lett; 2007 Jun; 17(12):3373-7. PubMed ID: 17434732
[TBL] [Abstract][Full Text] [Related]
6. Discovery and preclinical profile of Saxagliptin (BMS-477118): a highly potent, long-acting, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes.
Augeri DJ; Robl JA; Betebenner DA; Magnin DR; Khanna A; Robertson JG; Wang A; Simpkins LM; Taunk P; Huang Q; Han SP; Abboa-Offei B; Cap M; Xin L; Tao L; Tozzo E; Welzel GE; Egan DM; Marcinkeviciene J; Chang SY; Biller SA; Kirby MS; Parker RA; Hamann LG
J Med Chem; 2005 Jul; 48(15):5025-37. PubMed ID: 16033281
[TBL] [Abstract][Full Text] [Related]
7. Discovery of potent, selective, and orally bioavailable pyridone-based dipeptidyl peptidase-4 inhibitors.
Xu J; Wei L; Mathvink R; Edmondson SD; Mastracchio A; Eiermann GJ; He H; Leone JF; Leiting B; Lyons KA; Marsilio F; Patel RA; Petrov A; Wu JK; Thornberry NA; Weber AE
Bioorg Med Chem Lett; 2006 Mar; 16(5):1346-9. PubMed ID: 16332437
[TBL] [Abstract][Full Text] [Related]
8. Substituted pyrrolidine-2,4-dicarboxylic acid amides as potent dipeptidyl peptidase IV inhibitors.
Tsai TY; Coumar MS; Hsu T; Hsieh HP; Chien CH; Chen CT; Chang CN; Lo YK; Wu SH; Huang CY; Huang YW; Wang MH; Wu HY; Lee HJ; Chen X; Chao YS; Jiaang WT
Bioorg Med Chem Lett; 2006 Jun; 16(12):3268-72. PubMed ID: 16581245
[TBL] [Abstract][Full Text] [Related]
9. Lead discovery of quinoxalinediones as an inhibitor of dipeptidyl peptidase-IV (DPP-IV) by high-throughput screening.
Cheon HG; Lee CM; Kim BT; Hwang KJ
Bioorg Med Chem Lett; 2004 May; 14(10):2661-4. PubMed ID: 15109673
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and structure-activity relationships of potent 4-fluoro-2-cyanopyrrolidine dipeptidyl peptidase IV inhibitors.
Fukushima H; Hiratate A; Takahashi M; Mikami A; Saito-Hori M; Munetomo E; Kitano K; Chonan S; Saito H; Suzuki A; Takaoka Y; Yamamoto K
Bioorg Med Chem; 2008 Apr; 16(7):4093-106. PubMed ID: 18243000
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, and biological evaluation of triazolopiperazine-based beta-amino amides as potent, orally active dipeptidyl peptidase IV (DPP-4) inhibitors.
Kowalchick JE; Leiting B; Pryor KD; Marsilio F; Wu JK; He H; Lyons KA; Eiermann GJ; Petrov A; Scapin G; Patel RA; Thornberry NA; Weber AE; Kim D
Bioorg Med Chem Lett; 2007 Nov; 17(21):5934-9. PubMed ID: 17827003
[TBL] [Abstract][Full Text] [Related]
12. (3R,4S)-4-(2,4,5-Trifluorophenyl)-pyrrolidin-3-ylamine inhibitors of dipeptidyl peptidase IV: synthesis, in vitro, in vivo, and X-ray crystallographic characterization.
Wright SW; Ammirati MJ; Andrews KM; Brodeur AM; Danley DE; Doran SD; Lillquist JS; Liu S; McClure LD; McPherson RK; Olson TV; Orena SJ; Parker JC; Rocke BN; Soeller WC; Soglia CB; Treadway JL; Vanvolkenburg MA; Zhao Z; Cox ED
Bioorg Med Chem Lett; 2007 Oct; 17(20):5638-42. PubMed ID: 17822893
[TBL] [Abstract][Full Text] [Related]
13. Discovery, structure-activity relationship, and pharmacological evaluation of (5-substituted-pyrrolidinyl-2-carbonyl)-2-cyanopyrrolidines as potent dipeptidyl peptidase IV inhibitors.
Pei Z; Li X; Longenecker K; von Geldern TW; Wiedeman PE; Lubben TH; Zinker BA; Stewart K; Ballaron SJ; Stashko MA; Mika AK; Beno DW; Long M; Wells H; Kempf-Grote AJ; Madar DJ; McDermott TS; Bhagavatula L; Fickes MG; Pireh D; Solomon LR; Lake MR; Edalji R; Fry EH; Sham HL; Trevillyan JM
J Med Chem; 2006 Jun; 49(12):3520-35. PubMed ID: 16759095
[TBL] [Abstract][Full Text] [Related]
14. From lead to preclinical candidate: optimization of beta-homophenylalanine based inhibitors of dipeptidyl peptidase IV.
Nordhoff S; López-Canet M; Hoffmann-Enger B; Bulat S; Cerezo-Gálvez S; Hill O; Rosenbaum C; Rummey C; Thiemann M; Matassa VG; Edwards PJ; Feurer A
Bioorg Med Chem Lett; 2009 Aug; 19(16):4818-23. PubMed ID: 19576767
[TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of long-acting inhibitors of dipeptidyl peptidase IV.
Kondo T; Sugimoto I; Nekado T; Ochi K; Ohtani T; Tajima Y; Yamamoto S; Kawabata K; Nakai H; Toda M
Bioorg Med Chem; 2007 Apr; 15(7):2715-35. PubMed ID: 17292611
[TBL] [Abstract][Full Text] [Related]
16. Discovery of 3-aminopiperidines as potent, selective, and orally bioavailable dipeptidyl peptidase IV inhibitors.
Cox JM; Harper B; Mastracchio A; Leiting B; Sinha Roy R; Patel RA; Wu JK; Lyons KA; He H; Xu S; Zhu B; Thornberry NA; Weber AE; Edmondson SD
Bioorg Med Chem Lett; 2007 Aug; 17(16):4579-83. PubMed ID: 17562364
[TBL] [Abstract][Full Text] [Related]
17. (2S,3S)-3-Amino-4-(3,3-difluoropyrrolidin-1-yl)-N,N-dimethyl-4-oxo-2-(4-[1,2,4]triazolo[1,5-a]-pyridin-6-ylphenyl)butanamide: a selective alpha-amino amide dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes.
Edmondson SD; Mastracchio A; Mathvink RJ; He J; Harper B; Park YJ; Beconi M; Di Salvo J; Eiermann GJ; He H; Leiting B; Leone JF; Levorse DA; Lyons K; Patel RA; Patel SB; Petrov A; Scapin G; Shang J; Roy RS; Smith A; Wu JK; Xu S; Zhu B; Thornberry NA; Weber AE
J Med Chem; 2006 Jun; 49(12):3614-27. PubMed ID: 16759103
[TBL] [Abstract][Full Text] [Related]
18. Discovery of potent and selective dipeptidyl peptidase IV inhibitors derived from beta-aminoamides bearing subsituted triazolopiperazines.
Kim D; Kowalchick JE; Brockunier LL; Parmee ER; Eiermann GJ; Fisher MH; He H; Leiting B; Lyons K; Scapin G; Patel SB; Petrov A; Pryor KD; Roy RS; Wu JK; Zhang X; Wyvratt MJ; Zhang BB; Zhu L; Thornberry NA; Weber AE
J Med Chem; 2008 Feb; 51(3):589-602. PubMed ID: 18201067
[TBL] [Abstract][Full Text] [Related]
19. First synthesis and determination of the absolute configuration of sulphostin, a novel inhibitor of dipeptidyl peptidase IV.
Abe M; Akiyama T; Nakamura H; Kojima F; Harada S; Muraoka Y
J Nat Prod; 2004 Jun; 67(6):999-1004. PubMed ID: 15217282
[TBL] [Abstract][Full Text] [Related]
20. 2-Cyano-4-fluoro-1-thiovalylpyrrolidine analogues as potent inhibitors of DPP-IV.
Haffner CD; McDougald DL; Reister SM; Thompson BD; Conlee C; Fang J; Bass J; Lenhard JM; Croom D; Secosky-Chang MB; Tomaszek T; McConn D; Wells-Knecht K; Johnson PR
Bioorg Med Chem Lett; 2005 Dec; 15(23):5257-61. PubMed ID: 16168640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
